loadpatents
name:-0.043428897857666
name:-0.25313901901245
name:-0.0079531669616699
PARIKH; Indu Patent Filings

PARIKH; Indu

Patent Applications and Registrations

Patent applications and USPTO patent grants for PARIKH; Indu.The latest application filed is for "peptides and methods of use thereof in treating uveitis".

Company Profile
3.34.30
  • PARIKH; Indu - Durham NC
  • PARIKH; Indu - Chapel Hill NC
  • Parikh; Indu - Verdun CA
  • Parikh; Indu - Ile de Soeurs Verdun CA
  • PARIKH, INDU - LLE DE SOEURS VERDUN CA
  • Parikh; Indu - Baltimore MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Peptides And Methods Of Use Thereof In Treating Uveitis
App 20220305078 - PARIKH; Indu ;   et al.
2022-09-29
Methods For Attenuating Release Of Inflammatory Mediators And Peptides Useful Therein
App 20210260154 - PARIKH; Indu
2021-08-26
Inhibitors Of Metastasis
App 20210130403 - PARIKH; Indu ;   et al.
2021-05-06
Inhibitors of metastasis
Grant 10,683,328 - Parikh , et al.
2020-06-16
Methods For Attenuating Release Of Inflammatory Mediators And Peptides Useful Therein
App 20200138898 - PARIKH; Indu
2020-05-07
Inhibitors Of Metastasis
App 20190119320 - PARIKH; Indu ;   et al.
2019-04-25
Inhibitors of metastasis
Grant 10,011,636 - Parikh , et al. July 3, 2
2018-07-03
Methods For Attenuating Release Of Inflammatory Mediators And Peptides Useful Therein
App 20180036367 - PARIKH; Indu
2018-02-08
Methods for attenuating release of inflammatory mediators and peptides useful therein
Grant 9,827,287 - Parikh November 28, 2
2017-11-28
Inhibitors Of Metastasis
App 20170121369 - PARIKH; Indu ;   et al.
2017-05-04
Mucin hypersecretion inhibitors and methods of use
Grant 9,598,463 - Parikh March 21, 2
2017-03-21
Inhibitors of metastasis
Grant 9,408,886 - Parikh , et al. August 9, 2
2016-08-09
Methods For Attenuating Release Of Inflammatory Mediators And Peptides Useful Therein
App 20160030509 - PARIKH; Indu
2016-02-04
Mucin Hypersecretion Inhibitors And Methods Of Use
App 20150274778 - PARIKH; Indu
2015-10-01
Methods for attenuating release of inflammatory mediators and peptides useful therein
Grant 8,999,915 - Parikh April 7, 2
2015-04-07
Mucin hypersecretion inhibitors and methods of use
Grant 8,907,056 - Parikh December 9, 2
2014-12-09
Inhibitors Of Metastasis
App 20140302057 - PARIKH; Indu ;   et al.
2014-10-09
Mucin Hypersecretion Inhibitors And Methods Of Use
App 20130338085 - PARIKH; Indu
2013-12-19
Methods for regulating inflammatory mediators and peptides for useful therein
Grant 8,563,689 - Takashi , et al. October 22, 2
2013-10-22
Methods of reducing inflammation and mucus hypersecretion
Grant 8,501,911 - Li , et al. August 6, 2
2013-08-06
Mucin hypersecretion inhibitors and methods of use
Grant 8,492,518 - Parikh July 23, 2
2013-07-23
Mucin hypersecretion inhibitors and methods of use
Grant 8,293,870 - Parikh October 23, 2
2012-10-23
Microparticles of water-insoluble substances
Grant 8,206,746 - Parikh , et al. June 26, 2
2012-06-26
Fibrate-statin Combinations with Reduced Fed-fasted Effects
App 20120064160 - Guivarc'h; Pol-Henri ;   et al.
2012-03-15
Dispersible Phospholipid Stabilized Microparticles
App 20110244032 - Parikh; Indu ;   et al.
2011-10-06
Process for preparing a rapidly dispersing solid drug dosage form
Grant 7,939,106 - Parikh , et al. May 10, 2
2011-05-10
Process for preparing a rapidly dispersing solid drug dosage form
Grant 7,939,105 - Parikh , et al. May 10, 2
2011-05-10
Mucin Hypersecretion Inhibitors And Methods Of Use
App 20100197607 - PARIKH; Indu
2010-08-05
Mucin Hypersecretion Inhibitors And Methods Of Use
App 20090275520 - PARIKH; Indu
2009-11-05
Methods Of Reducing Inflammation And Mucus Hypersecretion
App 20090220581 - LI; Yuehua ;   et al.
2009-09-03
Methods For Attenuating Release Of Inflammatory Mediators And Peptides Useful Therein
App 20090203620 - PARIKH; Indu
2009-08-13
Methods for regulating inflammatory mediators and peptides useful therein
Grant 7,544,772 - Takashi , et al. June 9, 2
2009-06-09
Mucin hypersecretion inhibitors and methods of use
Grant 7,524,926 - Parikh April 28, 2
2009-04-28
Treatment for Diabetes
App 20090041731 - Parikh; Indu ;   et al.
2009-02-12
Fenofibrate microparticles
Grant 7,255,877 - Parikh August 14, 2
2007-08-14
Methods for regulating inflammatory mediators and peptides useful therein
App 20060217307 - Takashi; Shuji ;   et al.
2006-09-28
Mucin hypersecretion inhibitors and methods of use
App 20060205664 - Parikh; Indu
2006-09-14
Anticancer compositions
Grant 6,979,456 - Parikh , et al. December 27, 2
2005-12-27
Treatment for diabetes
App 20040209816 - Parikh, Indu ;   et al.
2004-10-21
Fibrate-statin combinations with reduced fed-fasted effects
App 20040086571 - Guivarc'h, Pol-Henri ;   et al.
2004-05-06
Spray drying process and compositions of fenofibrate
Grant 6,696,084 - Pace , et al. February 24, 2
2004-02-24
Dispersible phospholipid stabilized microparticles
App 20030206949 - Parikh, Indu ;   et al.
2003-11-06
Microparticles of water-insoluble substances
App 20030180367 - Parikh, Indu ;   et al.
2003-09-25
Fibrate-statin combinations with reduced fed-fasted effects
App 20020161032 - Guivarc'h, Pol-Henri W. ;   et al.
2002-10-31
Cyclosporiine particles
Grant 6,465,016 - Parikh , et al. October 15, 2
2002-10-15
Fenofibrate Microparticles
App 20020119199 - PARIKH, INDU
2002-08-29
Dispersible Phospholipid Stabilized Microparticles
App 20020106403 - PARIKH, INDU ;   et al.
2002-08-08
Treatment for diabetes
App 20020081285 - Parikh, Indu ;   et al.
2002-06-27
Spray drying process and compositions of fenofibrate
App 20020056206 - Pace, Gary W. ;   et al.
2002-05-16
Cyclosporiine particles
App 20020013271 - Parikh, Indu ;   et al.
2002-01-31
Composition and method of preparing microparticles of water-insoluble substances
Grant 6,228,399 - Parikh , et al. May 8, 2
2001-05-08
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
Grant 6,086,376 - Moussa , et al. July 11, 2
2000-07-11
Composition and method of preparing microparticles of water-insoluble substances
Grant 5,922,355 - Parikh , et al. July 13, 1
1999-07-13
Adjuvant compositions and vaccine formulations comprising same
Grant 5,785,975 - Parikh July 28, 1
1998-07-28
Cyclosporin emulsions
Grant 5,660,858 - Parikh , et al. August 26, 1
1997-08-26
Polysaccharide matrices comprising macromolecular spacer arms for use as adsorbents in affinity chromatography techniques
Grant 4,411,832 - Cuatrecasas , et al. * October 25, 1
1983-10-25
Diagnostic reagent
Grant 4,298,685 - Parikh , et al. November 3, 1
1981-11-03
Affinity chromatography of Vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
Grant 4,225,487 - Cuatrecasas , et al. September 30, 1
1980-09-30
Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
Grant 4,125,492 - Cuatrecasas , et al. November 14, 1
1978-11-14
Polysaccharide matrices for use as adsorbents in affinity chromatography techniques
Grant 3,947,352 - Cuatrecasas , et al. March 30, 1
1976-03-30
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed